CNS
Price
$86.44
Change
+$1.77 (+2.09%)
Updated
Jan 14 closing price
Capitalization
3.7B
7 days until earnings call
PX
Price
$12.99
Change
+$0.22 (+1.72%)
Updated
Jan 14 closing price
Capitalization
975.69M
42 days until earnings call
Ad is loading...

CNS vs PX

Header iconCNS vs PX Comparison
Open Charts CNS vs PXBanner chart's image
Cohen & Steers
Price$86.44
Change+$1.77 (+2.09%)
Volume$239.01K
Capitalization3.7B
P10
Price$12.99
Change+$0.22 (+1.72%)
Volume$417.99K
Capitalization975.69M
CNS vs PX Comparison Chart
Loading...
CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNS vs. PX commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNS is a StrongBuy and PX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (CNS: $86.44 vs. PX: $12.99)
Brand notoriety: CNS and PX are both not notable
Both companies represent the Investment Managers industry
Current volume relative to the 65-day Moving Average: CNS: 137% vs. PX: 48%
Market capitalization -- CNS: $3.7B vs. PX: $975.69M
CNS [@Investment Managers] is valued at $3.7B. PX’s [@Investment Managers] market capitalization is $975.69M. The market cap for tickers in the [@Investment Managers] industry ranges from $124.17B to $0. The average market capitalization across the [@Investment Managers] industry is $5.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNS’s FA Score shows that 1 FA rating(s) are green whilePX’s FA Score has 0 green FA rating(s).

  • CNS’s FA Score: 1 green, 4 red.
  • PX’s FA Score: 0 green, 5 red.
According to our system of comparison, CNS is a better buy in the long-term than PX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNS’s TA Score shows that 4 TA indicator(s) are bullish while PX’s TA Score has 4 bullish TA indicator(s).

  • CNS’s TA Score: 4 bullish, 4 bearish.
  • PX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CNS and PX are a good buy in the short-term.

Price Growth

CNS (@Investment Managers) experienced а -3.37% price change this week, while PX (@Investment Managers) price change was -1.52% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -1.14%. For the same industry, the average monthly price growth was -2.94%, and the average quarterly price growth was +4.85%.

Reported Earning Dates

CNS is expected to report earnings on Apr 16, 2025.

PX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Investment Managers (-1.14% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNS($3.7B) has a higher market cap than PX($976M). PX has higher P/E ratio than CNS: PX (92.20) vs CNS (28.73). PX YTD gains are higher at: 3.013 vs. CNS (-6.389). CNS has higher annual earnings (EBITDA): 184M vs. PX (48.7M). CNS has more cash in the bank: 265M vs. PX (30.5M). CNS has less debt than PX: CNS (140M) vs PX (310M). CNS has higher revenues than PX: CNS (490M) vs PX (242M).
CNSPXCNS / PX
Capitalization3.7B976M379%
EBITDA184M48.7M378%
Gain YTD-6.3893.013-212%
P/E Ratio28.7392.2031%
Revenue490M242M202%
Total Cash265M30.5M869%
Total Debt140M310M45%
FUNDAMENTALS RATINGS
CNS vs PX: Fundamental Ratings
CNS
PX
OUTLOOK RATING
1..100
7622
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
40100
SMR RATING
1..100
3086
PRICE GROWTH RATING
1..100
5941
P/E GROWTH RATING
1..100
3799
SEASONALITY SCORE
1..100
n/a36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNS's Valuation (91) in the Investment Managers industry is in the same range as PX (94) in the Chemicals Specialty industry. This means that CNS’s stock grew similarly to PX’s over the last 12 months.

CNS's Profit vs Risk Rating (40) in the Investment Managers industry is somewhat better than the same rating for PX (100) in the Chemicals Specialty industry. This means that CNS’s stock grew somewhat faster than PX’s over the last 12 months.

CNS's SMR Rating (30) in the Investment Managers industry is somewhat better than the same rating for PX (86) in the Chemicals Specialty industry. This means that CNS’s stock grew somewhat faster than PX’s over the last 12 months.

PX's Price Growth Rating (41) in the Chemicals Specialty industry is in the same range as CNS (59) in the Investment Managers industry. This means that PX’s stock grew similarly to CNS’s over the last 12 months.

CNS's P/E Growth Rating (37) in the Investment Managers industry is somewhat better than the same rating for PX (99) in the Chemicals Specialty industry. This means that CNS’s stock grew somewhat faster than PX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNSPX
RSI
ODDS (%)
Bullish Trend 7 days ago
65%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
59%
Bearish Trend 7 days ago
73%
Momentum
ODDS (%)
Bearish Trend 7 days ago
67%
Bullish Trend 7 days ago
73%
MACD
ODDS (%)
N/A
Bullish Trend 7 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
63%
Bullish Trend 7 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
67%
Bearish Trend 7 days ago
77%
Advances
ODDS (%)
Bullish Trend 20 days ago
65%
Bullish Trend 7 days ago
69%
Declines
ODDS (%)
Bearish Trend 8 days ago
62%
Bearish Trend 16 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
63%
Bearish Trend 7 days ago
63%
Aroon
ODDS (%)
Bearish Trend 7 days ago
63%
Bearish Trend 7 days ago
78%
View a ticker or compare two or three
Ad is loading...
CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMGGX48.820.53
+1.10%
Franklin Small-Mid Cap Growth R6
RLBBX33.970.07
+0.21%
American Funds American Balanced R2
NEFSX42.990.04
+0.09%
Natixis US Equity Opportunities A
IEYYX9.05N/A
N/A
Macquarie Climate Solutions Y
NSGRX24.97N/A
N/A
Northern Small Cap Core I